HCMI has released 148 patient-derived next-generation cancer models from 18 tumor types! Masked somatic MAF data are now available for a subset of models. Users can now search and filter these models by available somatic variants on the HCMI Searchable Catalog.
HCMI: Human Cancer Models Initiative
The Human Cancer Models Initiative (HCMI) is an international consortium that is generating novel, next-generation, tumor-derived culture models annotated with clinical, biospecimen, and molecular characterization data. HCMI-developed models and case-associated data are available as a community resource. NCI is contributing to the initiative by supporting four Cancer Model Development Centers (CMDCs).